Nanologica AB (publ)

At a glance

Most recent filing on June 29, 2021 — an open-market purchase by Sverre Bengtsson on Apr 6, 2020.

We hold 1 visible filing, going back to April 6, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 1 shown

This page is free to read, and it stops after 1 row. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Sverre Bengtsson Closely associated: Director Drug Development
170,000 SEKOpen-market buy
TradedApr 6, 2020FiledJun 29, 2021